Jilin Jian Yisheng Pharmaceutical Co Ltd
SZSE:002566
Intrinsic Value
Jilin Jian Yisheng Pharmaceutical Co., Ltd. engages in the research and development, production, and distribution of Chinese patent medicines. [ Read More ]
The intrinsic value of one
Jilin Jian Yisheng Pharmaceutical Co Ltd
stock under the Base Case scenario is
6.36
CNY.
Compared to the current market price of 7.32 CNY,
Jilin Jian Yisheng Pharmaceutical Co Ltd
is
Overvalued by 13%.
Jilin Jian Yisheng Pharmaceutical Co Ltd's market capitalization is 2.4B CNY.
Jilin Jian Yisheng Pharmaceutical Co Ltd stock price is 7.32 CNY.
Jilin Jian Yisheng Pharmaceutical Co Ltd stock (6.36 CNY) is 13% less than its price (7.32 CNY).
Jilin Jian Yisheng Pharmaceutical Co Ltd stock (5.3 CNY) is 28% less than its price (7.32 CNY). Open DCF Valuation
Jilin Jian Yisheng Pharmaceutical Co Ltd stock price (7.32 CNY) is 1% less than its Relative Value (7.42 CNY). Open Relative Valuation
Jilin Jian Yisheng Pharmaceutical Co Ltd.
Jilin Jian Yisheng Pharmaceutical Co Ltd has positive Net Income for the last twelve months.
Jilin Jian Yisheng Pharmaceutical Co Ltd's ROE (Return on Equity) has decreased in the last 3 years from 4% to 4%.
Jilin Jian Yisheng Pharmaceutical Co Ltd's Revenue has grown by 4% over the past 12 months.
Jilin Jian Yisheng Pharmaceutical Co Ltd's ROIC (Return on Invested Capital) has decreased in the last 3 years from 5% to 3%.
Jilin Jian Yisheng Pharmaceutical Co Ltd's Revenue has been falling by 1% per year for the last 3 years.
Jilin Jian Yisheng Pharmaceutical Co Ltd has positive Operating Income for the last twelve months.
Jilin Jian Yisheng Pharmaceutical Co Ltd's ROE (Return on Equity) for the past 12 months is very low and is equal to 4%.
Jilin Jian Yisheng Pharmaceutical Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 3%.
Jilin Jian Yisheng Pharmaceutical Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (547m CNY) than debt (478m CNY).
Jilin Jian Yisheng Pharmaceutical Co Ltd has a very low three-year average ROE (Return on Equity): 4%. The company is not efficient at transforming stockholders' equity into net income.
Jilin Jian Yisheng Pharmaceutical Co Ltd has a very low three-year average ROIC (Return on Invested Capital): 4%. The company is not efficient at using invested capital to generate operating income.
Jilin Jian Yisheng Pharmaceutical Co Ltd has positive Free Cash Flow for the last twelve months.
Jilin Jian Yisheng Pharmaceutical Co Ltd has positive Gross Profit for the last twelve months.
Jilin Jian Yisheng Pharmaceutical Co Ltd's Altman Z-Score is very high and is equal to 3.69.
Jilin Jian Yisheng Pharmaceutical Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.22.
Jilin Jian Yisheng Pharmaceutical Co Ltd's long-term assets (3B CNY) exceed its long-term liabilties (836m CNY).
Jilin Jian Yisheng Pharmaceutical Co Ltd's short-term assets (2B CNY) exceed its short-term liabilties (613m CNY).
Valuation Backtest
Jilin Jian Yisheng Pharmaceutical Co Ltd
Run backtest to discover the historical profit from buying and selling
Jilin Jian Yisheng Pharmaceutical Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Jilin Jian Yisheng Pharmaceutical Co Ltd
Balance Sheet Decomposition
Jilin Jian Yisheng Pharmaceutical Co Ltd
| Current Assets | 2.4B |
| Cash & Short-Term Investments | 547m |
| Receivables | 232m |
| Other Current Assets | 1.6B |
| Non-Current Assets | 632.3m |
| PP&E | 497.9m |
| Intangibles | 116.8m |
| Other Non-Current Assets | 17.6m |
| Current Liabilities | 612.5m |
| Accounts Payable | 24.8m |
| Accrued Liabilities | 7m |
| Short-Term Debt | 470.4m |
| Other Current Liabilities | 110.4m |
| Non-Current Liabilities | 223.6m |
| Long-Term Debt | 7.3m |
| Other Non-Current Liabilities | 216.3m |
Earnings Waterfall
Jilin Jian Yisheng Pharmaceutical Co Ltd
|
Revenue
|
858.3m
CNY
|
|
Cost of Revenue
|
-252.2m
CNY
|
|
Gross Profit
|
606.1m
CNY
|
|
Operating Expenses
|
-509.6m
CNY
|
|
Operating Income
|
96.5m
CNY
|
|
Other Expenses
|
-15.2m
CNY
|
|
Net Income
|
81.2m
CNY
|
Free Cash Flow Analysis
Jilin Jian Yisheng Pharmaceutical Co Ltd
Profitability Score
Profitability Due Diligence
Jilin Jian Yisheng Pharmaceutical Co Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
Jilin Jian Yisheng Pharmaceutical Co Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Jilin Jian Yisheng Pharmaceutical Co Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
Jilin Jian Yisheng Pharmaceutical Co Ltd's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Jilin Jian Yisheng Pharmaceutical Co Ltd
Shareholder Return
Price
Jilin Jian Yisheng Pharmaceutical Co Ltd
| Average Annual Return | 8.63% |
| Standard Deviation of Annual Returns | 28.69% |
| Max Drawdown | -54% |
| Market Capitalization | 2.4B CNY |
| Shares Outstanding | 330 951 600 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Jilin Jian Yisheng Pharmaceutical Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Jilin Jian Yisheng Pharmaceutical Co., Ltd. engages in the research and development, production, and distribution of Chinese patent medicines. The company is headquartered in Tonghua, Jilin and currently employs 1,712 full-time employees. The company went IPO on 2011-03-18. The Company’s main products consist of Shengmai injections, Zhenyuan capsules, Xinyue capsules, Qingkailing injections and Guifu Dihuang capsules, among others. The firm's products are applied in the treatment for heart cerebrovascular diseases and detoxification. The firm also provides health care products and cosmetics. The firm distributes its products within China market.
Contact
IPO
Employees
Officers
The intrinsic value of one
Jilin Jian Yisheng Pharmaceutical Co Ltd
stock under the Base Case scenario is
6.36
CNY.
Compared to the current market price of 7.32 CNY,
Jilin Jian Yisheng Pharmaceutical Co Ltd
is
Overvalued by 13%.
You don't have any saved screeners yet
